Bioaffinity Technologiew-27BIAFWPreferred / convertible
13F holders, Q4 2025 (December 31)3holders
0new positions
0sold out
1famous investor
$0.35avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding Bioaffinity Technologiew-27 (BIAFW) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were Clear Street Group Inc. ($19K), UBS Group AG ($16K) and Citadel Advisors ($8K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologiew-27
- CUSIP
- 09076W117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 8,485 shares sold, net −8,485 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Clear Street Group Inc. | — | Reduce -0.5% | 55,041 | $19K |
| UBS Group AG | — | Reduce -2.4% | 46,549 | $16K |
| Citadel Advisors | — | Reduce -23.2% | 23,498 | $8K |
"% of holder's portfolio" is BIAFW's weight in each manager's 13F, not the share of Bioaffinity Technologiew-27 the manager owns.